Detalhe da pesquisa
1.
A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity.
N Engl J Med
; 382(22): 2117-2128, 2020 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32233338
2.
Liraglutide in Children and Adolescents with Type 2 Diabetes.
N Engl J Med
; 381(7): 637-646, 2019 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31034184
3.
Liraglutide for Adolescents with Obesity. Reply.
N Engl J Med
; 383(12): 1193-1194, 2020 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32937058
4.
Liraglutide in an Adolescent Population with Obesity: A Randomized, Double-Blind, Placebo-Controlled 5-Week Trial to Assess Safety, Tolerability, and Pharmacokinetics of Liraglutide in Adolescents Aged 12-17 Years.
J Pediatr
; 181: 146-153.e3, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27979579
5.
Evaluating potential predictors of weight loss response to liraglutide in adolescents with obesity: A post hoc analysis of the randomized, placebo-controlled SCALE Teens trial.
Pediatr Obes
; 18(9): e13061, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37264767
6.
Liraglutide for Weight Management in Children and Adolescents With Prader-Willi Syndrome and Obesity.
J Clin Endocrinol Metab
; 108(1): 4-12, 2022 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36181471
7.
Liraglutide pharmacokinetics and exposure-response in adolescents with obesity.
Pediatr Obes
; 16(10): e12799, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33963681
8.
Effect of liraglutide treatment on body mass index and weight parameters in children and adolescents with type 2 diabetes: Post hoc analysis of the ellipse trial.
Pediatr Obes
; 16(8): e12778, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33634589
9.
Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial.
Lancet
; 373(9662): 473-81, 2009 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-18819705
10.
Liraglutide pharmacokinetics and exposure-response in pediatric patients with type 2 diabetes.
J Pediatr Endocrinol Metab
; 33(10): 1289-1292, 2020 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32817582
11.
Liraglutide effects in a paediatric (7-11 y) population with obesity: A randomized, double-blind, placebo-controlled, short-term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics.
Pediatr Obes
; 14(5): e12495, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30653847
12.
Efficacy and safety of combination therapy: repaglinide plus metformin versus nateglinide plus metformin.
Diabetes Care
; 26(7): 2063-8, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12832314
13.
Repaglinide versus nateglinide monotherapy: a randomized, multicenter study.
Diabetes Care
; 27(6): 1265-70, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15161773
14.
Medullary Thyroid Carcinoma Surveillance Study: A Case-Series Registry.
Thyroid
; 30(10): 1397-1398, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32316860
15.
Treatment of type 2 diabetes with a combination regimen of repaglinide plus pioglitazone.
Diabetes Res Clin Pract
; 63(2): 127-34, 2004 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-14739053
16.
Assessment of growth and immunologic function in HIV-infected and exposed children.
J Assoc Nurses AIDS Care
; 13(3): 37-45, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12064020
17.
Liraglutide's safety, tolerability, pharmacokinetics, and pharmacodynamics in pediatric type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
Diabetes Technol Ther
; 16(10): 679-87, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25036533
18.
Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD).
Diabetes Care
; 32(7): 1224-30, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19289857